1H-13C nuclear magnetic resonance assignment and structural characterization of HIV-1 Tat protein. 2000

J M Péloponèse, and C Grégoire, and S Opi, and D Esquieu, and J Sturgis, and E Lebrun, and E Meurs, and Y Collette, and D Olive, and A M Aubertin, and M Witvrow, and C Pannecouque, and E De Clercq, and C Bailly, and J Lebreton, and E P Loret
Laboratoire d'ingéniérie des systèmes macromoléculaires, Institut de biologie structurale et microbiologie, Marseilles, France.

Tat is a viral protein essential for activation of the HIV genes and plays an important role in the HIV-induced immunodeficiency. We chemically synthesized a Tat protein (86 residues) with its six glycines C alpha labelled with 13C. This synthetic protein has the full Tat activity. Heteronuclear nuclear magnetic resonance (NMR) spectra and NOE back-calculation made possible the sequential assignment of the 86 spin systems. Consequently, 915 NMR restraints were identified and 272 of them turned out to be long range ([i-j] > 4), providing structural information on the whole Tat protein. The poor spectral dispersion of Tat NMR spectra does not allow an accurate structure to be determined as for other proteins studied by 2D NMR. Nevertheless, we were able to determine the folding for Tat protein at a 1-mM protein concentration in a 100 mM, pH 4.5 phosphate buffer. The two main Tat functional regions, the basic region and the cysteine-rich region, are well exposed to solvent while a part of the N-terminal region and the C-terminal region constitute the core of Tat Bru. The basic region adopts an extended structure while the cysteine-rich region is made up of two loops. Resolution of this structure was determinant to develop a drug design approach against Tat. The chemical synthesis of the drugs allowed the specific binding and the inhibition of Tat to be verified.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015696 Gene Products, tat Trans-acting transcription factors produced by retroviruses such as HIV. They are nuclear proteins whose expression is required for viral replication. The tat protein stimulates LONG TERMINAL REPEAT-driven RNA synthesis for both viral regulatory and viral structural proteins. Tat stands for trans-activation of transcription. tat Gene Products,tat Protein,Gene Product, tat,tat Gene Product
D054322 tat Gene Products, Human Immunodeficiency Virus Proteins encoded by the TAT GENES of the HUMAN IMMUNODEFICIENCY VIRUS. HIV Transacting Transcription Protein,HIV tat Protein,Trans-Acting Transcription Factor, HIV,Trans Acting Transcription Factor, HIV,tat Protein, HIV

Related Publications

J M Péloponèse, and C Grégoire, and S Opi, and D Esquieu, and J Sturgis, and E Lebrun, and E Meurs, and Y Collette, and D Olive, and A M Aubertin, and M Witvrow, and C Pannecouque, and E De Clercq, and C Bailly, and J Lebreton, and E P Loret
September 1998, Solid state nuclear magnetic resonance,
J M Péloponèse, and C Grégoire, and S Opi, and D Esquieu, and J Sturgis, and E Lebrun, and E Meurs, and Y Collette, and D Olive, and A M Aubertin, and M Witvrow, and C Pannecouque, and E De Clercq, and C Bailly, and J Lebreton, and E P Loret
October 1979, The Biochemical journal,
J M Péloponèse, and C Grégoire, and S Opi, and D Esquieu, and J Sturgis, and E Lebrun, and E Meurs, and Y Collette, and D Olive, and A M Aubertin, and M Witvrow, and C Pannecouque, and E De Clercq, and C Bailly, and J Lebreton, and E P Loret
January 2006, Journal of biomolecular NMR,
J M Péloponèse, and C Grégoire, and S Opi, and D Esquieu, and J Sturgis, and E Lebrun, and E Meurs, and Y Collette, and D Olive, and A M Aubertin, and M Witvrow, and C Pannecouque, and E De Clercq, and C Bailly, and J Lebreton, and E P Loret
October 1974, Carbohydrate research,
J M Péloponèse, and C Grégoire, and S Opi, and D Esquieu, and J Sturgis, and E Lebrun, and E Meurs, and Y Collette, and D Olive, and A M Aubertin, and M Witvrow, and C Pannecouque, and E De Clercq, and C Bailly, and J Lebreton, and E P Loret
January 1990, Methods in enzymology,
J M Péloponèse, and C Grégoire, and S Opi, and D Esquieu, and J Sturgis, and E Lebrun, and E Meurs, and Y Collette, and D Olive, and A M Aubertin, and M Witvrow, and C Pannecouque, and E De Clercq, and C Bailly, and J Lebreton, and E P Loret
January 1973, Annals of the New York Academy of Sciences,
J M Péloponèse, and C Grégoire, and S Opi, and D Esquieu, and J Sturgis, and E Lebrun, and E Meurs, and Y Collette, and D Olive, and A M Aubertin, and M Witvrow, and C Pannecouque, and E De Clercq, and C Bailly, and J Lebreton, and E P Loret
March 1984, The International journal of applied radiation and isotopes,
J M Péloponèse, and C Grégoire, and S Opi, and D Esquieu, and J Sturgis, and E Lebrun, and E Meurs, and Y Collette, and D Olive, and A M Aubertin, and M Witvrow, and C Pannecouque, and E De Clercq, and C Bailly, and J Lebreton, and E P Loret
August 1990, Journal of biochemistry,
J M Péloponèse, and C Grégoire, and S Opi, and D Esquieu, and J Sturgis, and E Lebrun, and E Meurs, and Y Collette, and D Olive, and A M Aubertin, and M Witvrow, and C Pannecouque, and E De Clercq, and C Bailly, and J Lebreton, and E P Loret
April 2016, Biomolecular NMR assignments,
J M Péloponèse, and C Grégoire, and S Opi, and D Esquieu, and J Sturgis, and E Lebrun, and E Meurs, and Y Collette, and D Olive, and A M Aubertin, and M Witvrow, and C Pannecouque, and E De Clercq, and C Bailly, and J Lebreton, and E P Loret
August 1990, Biochemistry,
Copied contents to your clipboard!